Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

Devaux Christian A

doi:10.17352/2455-2976.000122

Article Dans Une Revue Cardiology and Cardiovascular Medicine Année : 2020

Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

(1, 2)

1
2

Devaux Christian A

Fonction : Auteur

Microbes évolution phylogénie et infections

Institut Hospitalier Universitaire Méditerranée Infection

Domaines

Bactériologie Virologie Parasitologie Cardiologie et système cardiovasculaire Maladies émergentes Maladies infectieuses

Isabelle COMBE : Connectez-vous pour contacter le contributeur

https://amu.hal.science/hal-03027634

Soumis le : vendredi 27 novembre 2020-11:31:23

Dernière modification le : mercredi 15 novembre 2023-10:52:17

Dates et versions

hal-03027634 , version 1 (27-11-2020)

Identifiants

HAL Id : hal-03027634 , version 1
DOI : 10.17352/2455-2976.000122

Citer

Devaux Christian A. Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?. Cardiology and Cardiovascular Medicine, 2020, 7 (2), pp.101-103. ⟨10.17352/2455-2976.000122⟩. ⟨hal-03027634⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU

11 Consultations

0 Téléchargements

Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

Domaines

Dates et versions

Identifiants

Citer

Exporter

Collections

Altmetric

Partager